论著 · 基础研究

牙龈素提取物对口腔鳞癌细胞HN6生物学特性的影响

  • 李虎虓 ,
  • 李笑甜 ,
  • 赵旭日 ,
  • 张桓瑜 ,
  • 周薇 ,
  • 宋忠臣
展开
  • 1.上海交通大学医学院附属第九人民医院牙周病科,上海交通大学口腔医学院,国家口腔医学中心,国家口腔疾病临床医学研究中心,上海市口腔医学重点实验室,上海市口腔医学研究所,上海 200011
    2.上海交通大学医学院附属第九人民医院口腔微生态与系统性疾病实验室,上海交通大学口腔医学院,国家口腔医学中心,国家口腔疾病临床医学研究中心,上海市口腔医学重点实验室,上海 200125
李虎虓(1994—),男,硕士,住院医师;电子信箱:tentigerli@163.com
宋忠臣,电子信箱:szhongchen@sina.com

收稿日期: 2023-09-20

  录用日期: 2023-12-26

  网络出版日期: 2024-02-28

基金资助

国家自然科学基金(82071112);上海交通大学医学院附属第九人民医院“交叉基金”(JYJC202005)

Effects of gingipain extract on the biological characteristics of oral squamous cell carcinoma cell HN6

  • Huxiao LI ,
  • Xiaotian LI ,
  • Xuri ZHAO ,
  • Huanyu ZHANG ,
  • Wei ZHOU ,
  • Zhongchen SONG
Expand
  • 1.Department of Periodontology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Shanghai 200011, China
    2.Laboratory of Oral Microbiota and Systemic Disease, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology, Shanghai 200125, China
SONG Zhongchen, E-mail: szhongchen@sina.com.

Received date: 2023-09-20

  Accepted date: 2023-12-26

  Online published: 2024-02-28

Supported by

National Natural Science Foundation of China(82071112);Cross-disciplinary Research Fund of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine(JYJC202005)

摘要

目的·观察牙龈素提取物对口腔鳞状细胞癌(oral squamous cell carcinoma,OSCC)细胞HN6生物学特性的影响。方法·选取人OSCC细胞系HN6,加入牙龈卟啉单胞菌(Porphyromonas gingivalisP. gingivalis)牙龈素提取物进行培养。根据牙龈素提取物的蛋白浓度不同分为对照组(control组),及牙龈素提取物蛋白浓度3.125 μg/mL组、6.25 μg/mL组、12.5 μg/mL组、25 μg/mL组、50 μg/mL组和100 μg/mL组,培养24、48 h后,采用细胞计数试剂盒8(cell counting kit-8,CCK-8)检测牙龈素提取物对HN6细胞增殖活性的影响。后续其他实验,分为control组、25 μg/mL组和50 μg/mL组进行。通过流式细胞术检测牙龈素提取物对细胞周期的影响,划痕实验和Transwell实验检测细胞迁移和侵袭能力,实时荧光定量PCR(real-time PCR,RT-PCR)和Western blotting检测细胞E-cadherin和N-cadherin蛋白和基因的表达。结果·在牙龈素提取物刺激HN6细胞24 h时,相比较control组,牙龈素提取物蛋白浓度25 μg/mL组(P=0.025),50 μg/mL组(P=0.000)和100 μg/mL组(P=0.049)的HN6细胞增殖活性显著增加;当刺激48 h时,6.25 μg/mL组(P=0.024)、12.5 μg/mL组(P=0.006)、25 μg/mL组(P=0.000)、50 μg/mL组(P=0.000)和100 μg/mL组(P=0.000)均较control组HN6细胞增殖活性有显著增加。细胞周期检测结果显示,与control组相比,经牙龈素提取物刺激24 h,HN6细胞G1期比例下降,S+G2期比例显著性上升(25 μg/mL组:P=0.024;50 μg/mL组:P=0.001)。细胞迁移实验结果显示,与control组相比,随着牙龈素提取物浓度升高,划痕愈合的百分比显著增加(P=0.001)。细胞Transwell侵袭实验结果显示,与control组相比,随着牙龈素提取物浓度升高,细胞穿过小室底部的数量显著性增加。RT-PCR和Western blotting实验结果显示,与control组相比,随着牙龈素提取物浓度增加,HN6细胞中N-cadherin mRNA和蛋白表达量显著性增加,E-cadherin mRNA和蛋白表达量显著性减少。结论·牙龈素提取物对OSCC细胞HN6的增殖、迁移和侵袭有促进作用。

本文引用格式

李虎虓 , 李笑甜 , 赵旭日 , 张桓瑜 , 周薇 , 宋忠臣 . 牙龈素提取物对口腔鳞癌细胞HN6生物学特性的影响[J]. 上海交通大学学报(医学版), 2024 , 44(2) : 161 -168 . DOI: 10.3969/j.issn.1674-8115.2024.02.002

Abstract

Objective ·To observe the effects of gingipain extract on the biological characteristics of oral squamous cell carcinoma cell HN6. Methods ·The HN6 cell line was selected, cultivated, and divided into different groups based on the protein concentration of gingipain extract from Porphyromonas gingivalis: control group, 3.125 μg/mL group, 6.25 μg/mL group, 12.5 μg/mL group, 25 μg/mL group, 50 μg/mL group, and 100 μg/mL group. After 24 and 48 h of cultivation, CCK-8 assay was used to detect the effects of gingipain extract on HN6 cell proliferation activity. Subsequent experiments were divided into control group, 25 μg/mL group and 50 μg/mL group. Flow cytometry was used to examine the effects of gingipain extract on cell cycle. Scratch assay and Transwell assay were performed to evaluate cell migration and invasion ability. Real-time PCR (RT-PCR) and Western blotting were used to measure the expression of E-cadherin and N-cadherin proteins and genes in cells. Results ·Stimulated with gingipain extract for 24 h, the HN6 cells showed significantly increased proliferation activity in the 25 μg/mL (P=0.025), 50 μg/mL (P=0.000), and 100 μg/mL (P=0.049) groups compared to the control group. After 48 h, proliferation activity was significantly higher in the 6.25 μg/mL(P=0.024), 12.5 μg/mL (P=0.006), 25 μg/mL (P=0.000), 50 μg/mL (P=0.000), and 100 μg/mL (P=0.000) groups compared to the control group. Cell cycle analysis revealed that, after 24 h of gingipain stimulation, the proportion of HN6 cells in the G1 phase decreased, while the proportion in the S+G2 phase significantly increased compared to the control group (25 μg/mL group: P=0.024; 50 μg/mL group: P=0.001). Compared to the control group, the scratch assay demonstrated a significant increase in the percentage of scratch closure as the concentration of gingipain extract increased (P=0.001). Compared to the control group, the Transwell invasion assay showed a significant increase in the number of cells passing through the bottom of the chamber as the concentration of gingipain extract increased. RT-PCR and Western blotting results indicated that as the concentration of gingipain extract increased, the expression levels of N-cadherin mRNA and protein in HN6 cells significantly increased, while the expression levels of E-cadherin mRNA and protein significantly decreased compared to the control group. Conclusion ·Gingipain extract could promote proliferation, migration, and invasion of oral squamous cell carcinoma HN6 cells.

参考文献

1 KOMLóS G, CSURGAY K, HORVáTH F, et al. Periodontitis as a risk for oral cancer: a case-control study[J]. BMC Oral Health, 2021, 21(1): 640.
2 SANZ M, MARCO DEL CASTILLO A, JEPSEN S, et al. Periodontitis and cardiovascular diseases: consensus report[J]. J Clin Periodontol, 2020, 47(3): 268-288.
3 王兴. 第四次全国口腔健康流行病学调查报告[M]. 北京: 人民卫生出版社, 2018.
3 WANG X. Report on the Fourth National Epidemiological Survey of Oral Health[M]. Beijing: People's Health Publishing House, 2018.
4 KAVARTHAPU A, GURUMOORTHY K. Linking chronic periodontitis and oral cancer: a review[J]. Oral Oncol, 2021, 121: 105375.
5 ALLON I, ABBA M, KAPLAN I, et al. Oral variant of acantholytic squamous cell carcinoma: histochemical and immunohistochemical features[J]. Acta Histochem, 2019, 121(8): 151443.
6 MORRISON A G, SARKAR S, UMAR S, et al. The contribution of the human oral microbiome to oral disease: a review[J]. Microorganisms, 2023, 11(2): 318.
7 LAMONT R J, FITZSIMONDS Z R, WANG H Z, et al. Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma[J]. Periodontol 2000, 2022, 89(1): 154-165.
8 GENG F X, LIU J C, GUO Y, et al. Persistent exposure to Porphyromonas gingivalis promotes proliferative and invasion capabilities, and tumorigenic properties of human immortalized oral epithelial cells[J]. Front Cell Infect Microbiol, 2017, 7: 57.
9 KYLM? A K, SORSA T, JOUHI L, et al. Prognostic role of Porphyromonas gingivalis gingipain rgp and matrix metalloproteinase 9 in oropharyngeal squamous cell carcinoma[J]. Anticancer Res, 2022, 42(11): 5415-5430.
10 GUO K, LIU Y K, ZHOU H J, et al. Involvement of protein kinase C β-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion[J]. Cancer Sci, 2008, 99(3): 486-496.
11 张桓瑜, 江旖婷, 朱晓晨, 等. 牙龈素提取物对小鼠脑神经炎症的影响[J]. 上海交通大学学报(医学版), 2022, 42(5): 570-577.
11 ZHANG H Y, JIANG Y T, ZHU X C, et al. Effects of gingipain extracts on brain neuroinflammation in mice[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 570-577.
12 KOLIARAKIS I, MESSARITAKIS I, NIKOLOUZAKIS T K, et al. Oral bacteria and intestinal dysbiosis in colorectal cancer[J]. Int J Mol Sci, 2019, 20(17): 4146.
13 MALINOWSKI B, W?SIERSKA A, ZALEWSKA K, et al. The role of Tannerella forsythia and Porphyromonas gingivalis in pathogenesis of esophageal cancer[J]. Infect Agent Cancer, 2019, 14: 3.
14 TAN Q, MA X, YANG B, et al. Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils[J]. Gut Microbes, 2022, 14(1): 2073785.
15 GAO S G, LI S G, MA Z K, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer[J]. Infect Agent Cancer, 2016, 11: 3.
16 LIU Y W, YUAN X, CHEN K S, et al. Clinical significance and prognostic value of Porphyromonas gingivalis infection in lung cancer[J]. Transl Oncol, 2021, 14(1): 100972.
17 CHANG C R, WANG H Y, LIU J C, et al. Porphyromonas gingivalis infection promoted the proliferation of oral squamous cell carcinoma cells through the miR-21/PDCD4/AP-1 negative signaling pathway[J]. ACS Infect Dis, 2019, 5(8): 1336-1347.
18 WOO B H, KIM D J, CHOI J I, et al. Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential[J]. Oncotarget, 2017, 8(29): 46981-46992.
19 LIU S Y, ZHOU X D, PENG X, et al. Porphyromonas gingivalis promotes immunoevasion of oral cancer by protecting cancer from macrophage attack[J]. J Immunol, 2020, 205(1): 282-289.
20 INABA H, SUGITA H, KUBONIWA M, et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation[J]. Cell Microbiol, 2014, 16(1): 131-145.
21 OHSHIMA J, WANG Q, FITZSIMONDS Z R, et al. Streptococcus gordonii programs epithelial cells to resist ZEB2 induction by Porphyromonas gingivalis[J]. Proc Natl Acad Sci USA, 2019, 116(17): 8544-8553.
22 REN J L, HAN X, LOHNER H, et al. P. gingivalis infection upregulates PD-L1 expression on dendritic cells, suppresses CD8+ T-cell responses, and aggravates oral cancer[J]. Cancer Immunol Res, 2023, 11(3): 290-305.
23 WHEELOCK M J, JOHNSON K R. Cadherins as modulators of cellular phenotype[J]. Annu Rev Cell Dev Biol, 2003, 19: 207-235.
24 CHRISTOFORI G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression[J]. EMBO J, 2003, 22(10): 2318-2323.
25 LAMOUILLE S, XU J, DERYNCK R. Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014, 15(3): 178-196.
26 XU Z L, CHEN Z M, PENG M S, et al. MicroRNA miR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3[J]. Bioengineered, 2022, 13(2): 2673-2685.
27 PIERCEALL W E, WOODARD A S, MORROW J S, et al. Frequent alterations in E-cadherin and α- and β-catenin expression in human breast cancer cell lines[J]. Oncogene, 1995, 11(7): 1319-1326.
28 DERYCKE L D M, BRACKE M E. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling[J]. Int J Dev Biol, 2004, 48(5/6): 463-476.
29 GRABOWSKA M M, DAY M L. Soluble E-cadherin: more than a symptom of disease[J]. Front Biosci (Landmark Ed), 2012, 17(5): 1948-1964.
30 KATZ J, YANG Q B, ZHANG P, et al. Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains[J]. Infect Immun, 2002, 70(5): 2512-2518.
文章导航

/